TipRanks
Merck & Company (CH:6MK)
:6MK
Switzerland Market
6MK
Merck & Company
RESEARCH TOOLSreports

Merck & Company (6MK) Stock News & Sentiment

0 Followers
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
2d ago
AZN
MRK
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
Premium
Market News
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
7d ago
ICE
MRK
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
Premium
Market News
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
8d ago
MRK
VUG
Merck: Emerging Immunology Strength and HS Execution Support Unchanged $160 Price Target and Buy Rating
Premium
Ratings
Merck: Emerging Immunology Strength and HS Execution Support Unchanged $160 Price Target and Buy Rating
8d ago
MRK
Merck Buy Rating Reiterated as Compelling Tulisokibart Data and Diversified Pipeline Support Outlook; $170 Price Target Maintained
Premium
Ratings
Merck Buy Rating Reiterated as Compelling Tulisokibart Data and Diversified Pipeline Support Outlook; $170 Price Target Maintained
8d ago
MRK
3 ETF Bets with 11%+ Upside, According to AI Analyst
Premium
Market News
3 ETF Bets with 11%+ Upside, According to AI Analyst
10d ago
PH
CRM
3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst
Premium
Market News
3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst
16d ago
VZ
COP
More CH:6MK News >

6MK News on the Web

Health Care Select Sector SPDR (XLV) Adds Eli Lilly and JNJ on Oct. 7
GuruFocus News
Neutral
Merck price target lowered to $163 from $166 at BofA
TipRanks News
Neutral
Merck & Co. (MRK) -- Healthcare Innovation and Dividend Growth | Thornburg Investment ...
GuruFocus News
Bullish
Merck (MRK) Reports Positive Phase 2b Trial Results for Tulisokibart in Hidradenitis Suppurativa
GuruFocus News
Bullish
JPMorgan U.S. Momentum Factor ETF (JMOM) Buys $27.6 Million More Merck on Sept. 28
GuruFocus News
Neutral
Moderna has been on a tear since mid-August. Citi now sees it plunging 60%
CNBC
Neutral
3 ETF Bets with 11%+ Upside, According to AI Analyst
TipRanks News
Bullish
Merck Stock Slips 1.5% as $400 Million Buys KRAS Rights
GuruFocus News
Bearish

News Score - Last 7 Days

Neutral
CH:6MK
Sector Average
Media Buzz
This Week27 articles
Weekly Average30 articles
News Sentiment
This Week75%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:6MK’s Media Buzz Sentiment?
27 articles about CH:6MK were published this week. In an average week, 30 articles are published.
    What is CH:6MK’s weekly average amount of articles?
    In an average week, 30 articles about CH:6MK are published.
      What is CH:6MK’s News Sentiment?
      75% of articles about CH:6MK were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        MCKMcKesson
        ONCBeOne Medicines
        NVSNovartis
        NTRANatera
        Showing the stocks with the most bullish news sentiment over the past week